These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21906784)

  • 21. Guidance values for the biomonitoring of occupational exposure. State of the art.
    Aitio A
    Med Lav; 2006; 97(2):324-31. PubMed ID: 17017366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomonitoring Equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9).
    Hays SM; Nordberg M; Yager JW; Aylward LL
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S49-56. PubMed ID: 18579269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomonitoring Equivalents (BE) dossier for trihalomethanes.
    Aylward LL; LaKind JS; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S68-77. PubMed ID: 18579267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomonitoring Equivalents (BE) dossier for toluene (CAS No. 108-88-3).
    Aylward LL; Barton HA; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S27-36. PubMed ID: 18583006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategic biomonitoring initiatives: moving the science forward.
    Angerer J; Bird MG; Burke TA; Doerrer NG; Needham L; Robison SH; Sheldon L; Zenick H
    Toxicol Sci; 2006 Sep; 93(1):3-10. PubMed ID: 16785253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making sense of human biomonitoring data: findings and recommendations of a workshop.
    Bahadori T; Phillips RD; Money CD; Quackenboss JJ; Clewell HJ; Bus JS; Robison SH; Humphris CJ; Parekh AA; Osborn K; Kauffman RM
    J Expo Sci Environ Epidemiol; 2007 Jul; 17(4):308-13. PubMed ID: 17495868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomonitoring for occupational health risk assessment (BOHRA).
    Manno M; Viau C; ; Cocker J; Colosio C; Lowry L; Mutti A; Nordberg M; Wang S
    Toxicol Lett; 2010 Jan; 192(1):3-16. PubMed ID: 19446015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human exposure assessment and public health.
    Sexton K
    Prog Clin Biol Res; 1991; 372():455-66. PubMed ID: 1956939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human biomonitoring activities--programmes by industry.
    Boogaard PJ
    Int J Hyg Environ Health; 2007 May; 210(3-4):259-61. PubMed ID: 17275410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2,4-D exposure and risk assessment: comparison of external dose and biomonitoring based approaches.
    Hays SM; Aylward LL; Driver J; Ross J; Kirman C
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):481-9. PubMed ID: 23017741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human biomonitoring assessment values: approaches and data requirements.
    Angerer J; Aylward LL; Hays SM; Heinzow B; Wilhelm M
    Int J Hyg Environ Health; 2011 Sep; 214(5):348-60. PubMed ID: 21764371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Derivation of Biomonitoring Equivalents for cyfluthrin.
    Hays SM; Aylward LL; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):268-75. PubMed ID: 19751788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human milk biomonitoring data: interpretation and risk assessment issues.
    LaKind JS; Brent RL; Dourson ML; Kacew S; Koren G; Sonawane B; Tarzian AJ; Uhl K
    J Toxicol Environ Health A; 2005 Oct; 68(20):1713-69. PubMed ID: 16176917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative interpretation of human biomonitoring data.
    Clewell HJ; Tan YM; Campbell JL; Andersen ME
    Toxicol Appl Pharmacol; 2008 Aug; 231(1):122-33. PubMed ID: 18589468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomonitoring as a tool in the human health risk characterization of dermal exposure.
    Boogaard PJ
    Hum Exp Toxicol; 2008 Apr; 27(4):297-305. PubMed ID: 18684800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological monitoring guidance values for chemical incidents.
    Cocker J; Jones K; Bos PM
    Toxicol Lett; 2014 Dec; 231(3):324-7. PubMed ID: 24973493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7).
    Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S37-48. PubMed ID: 18579270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human exposure assessment to environmental chemicals using biomonitoring.
    Calafat AM; Ye X; Silva MJ; Kuklenyik Z; Needham LL
    Int J Androl; 2006 Feb; 29(1):166-71; discussion 181-5. PubMed ID: 16466536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concept of the Flemish human biomonitoring programme.
    Schoeters G; Den Hond E; Colles A; Loots I; Morrens B; Keune H; Bruckers L; Nawrot T; Sioen I; De Coster S; Van Larebeke N; Nelen V; Van de Mieroop E; Vrijens J; Croes K; Goeyens K; Baeyens W
    Int J Hyg Environ Health; 2012 Feb; 215(2):102-8. PubMed ID: 22178406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Derivation of Biomonitoring Equivalents for di(2-ethylhexyl)phthalate (CAS No. 117-81-7).
    Aylward LL; Hays SM; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):249-58. PubMed ID: 19751789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.